- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| ADVANCED BIOMED Aktie jetzt für 0€ handeln | |||||
| Fr | Advanced Biomed Inc. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 01.05. | Advanced Biomed Inc. - 8-K, Current Report | - | SEC Filings | ||
| 14.04. | Advanced Biomed sichert sich unbesicherten Kredit in Höhe von 600.000 US-Dollar | 2 | Investing.com Deutsch | ||
| 14.04. | Advanced Biomed Inc. - 8-K, Current Report | - | SEC Filings | ||
| 07.04. | Morning Market Movers: Advanced Biomed, Sky Quarry, Focus Universal, Kiora Pharmaceuticals See Big Swings | 665 | AFX News | WOONSOCKET (dpa-AFX) - At 8:40 a.m. ET on Tuesday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| 03.04. | Advanced Biomed Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 16.03. | Advanced Biomed Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 26.02. | Advanced Biomed Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 18.02. | Advanced Biomed announces 1-for-20 reverse stock split to regain Nasdaq compliance | 1 | Investing.com | ||
| 18.02. | Advanced Biomed Inc. Announces 1 for 20 Share Consolidation | 194 | GlobeNewswire (Europe) | Tainan City, Taiwan, Feb. 18, 2026 (GLOBE NEWSWIRE) -- Advanced Biomed Inc. (Nasdaq: ADVB) (the "Company" or "Advanced Biomed"), a biotechnology company focused on developing and commercializing innovative... ► Artikel lesen | |
| 13.02. | Advanced Biomed Inc. Announces 120-Case Feasibility Study with Chi-Mei Medical Center to Validate A+PerfusC - Integrated Perfusion 3D Cell Culture Platform for Precision Medicine and Drug Discovery | 2 | GlobeNewswire (USA) | ||
| 02.02. | Advanced Biomed Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 27.01. | Advanced Biomed Inc. regelt Schuldenrückzahlung von Tochtergesellschaft in Nachtragsvereinbarung | 1 | Investing.com Deutsch | ||
| 21.01. | Advanced Biomed Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 30.12.25 | Advanced Biomed Inc. - 8-K, Current Report | - | SEC Filings | ||
| 30.12.25 | Advanced Biomed-Aktie steigt nach Verkauf von Hongkong-Tochter | 1 | Investing.com Deutsch | ||
| 30.12.25 | Advanced Biomed veräußert Hongkong-Tochter für 23.000 US-Dollar | 1 | Investing.com Deutsch | ||
| 30.12.25 | Advanced Biomed sells Hong Kong subsidiary for $23,000 | 1 | Investing.com | ||
| 30.12.25 | Advanced Biomed Inc. Announces Disposal of its Hong Kong Subsidiary | 389 | GlobeNewswire (Europe) | Tainan City, Taiwan, Dec. 30, 2025 (GLOBE NEWSWIRE) -- Advanced Biomed Inc. (Nasdaq: ADVB) (the "Company", "Advanced Biomed"), a biotechnology company focused on developing and commercializing innovative... ► Artikel lesen | |
| 19.11.25 | Advanced Biomed Inc. - 10-Q, Quarterly Report | - | SEC Filings |
20 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| PLUS THERAPEUTICS | 4,970 | 0,00 % | Plus Therapeutics Inc.: Plus Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update on REYOBIQ Clinical Program and CNSide Commercial Rollout | HOUSTON, May 15, 2026 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) ("Plus" or the "Company"), a healthcare company developing and commercializing precision diagnostics and radiopharmaceuticals... ► Artikel lesen | |
| ORGANON | 11,500 | -0,30 % | Organon & Co.: Europäische Kommission erteilt Marktzulassung für POHERDY (Pertuzumab) von Henlius und Organon, das erste in Europa zugelassene Biosimilar zu PERJETA (Pertuzumab) | Shanghai Henlius Biotech, Inc. (2696.HK) und Organon (NYSE: OGN) gaben heute bekannt, dass die Europäische Kommission die Zulassung für POHERDY (Pertuzumab) 420 mg/14 ml Injektion zur intravenösen... ► Artikel lesen | |
| CO-DIAGNOSTICS | 1,285 | 0,00 % | Co-Diagnostics Reports First Quarter 2026 Financial Results | Advancing Global Commercialization Through CoSara Regulatory Progress and Regional Expansion
Executing Clinical Strategy with Upper Respiratory Submission Preparation... ► Artikel lesen | |
| SENSEONICS | 4,840 | -2,42 % | H.C. Wainwright cuts Senseonics stock price target on dilution | ||
| VIRIDIAN THERAPEUTICS | 14,500 | 0,00 % | XFRA 1S1: WIEDERAUFNAHME/RESUMPTION | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen | |
| INSPIRE MEDICAL SYSTEMS | 34,400 | -0,58 % | Inspire Medical Systems, Inc. Announces First Quarter 2026 Financial Results and Updates 2026 Guidance | First quarter revenue growth of 1.6%First quarter diluted EPS of $(0.39); adjusted diluted EPS of $0.10First quarter operating cash flow of $12.8 million MINNEAPOLIS, May 04, 2026 (GLOBE NEWSWIRE)... ► Artikel lesen | |
| VYOME | 1,870 | -1,06 % | Vyome: Positive Phase-2-Daten für Wundbehandlung bei Krebspatienten | ||
| EMBECTA | 2,780 | +3,04 % | Embecta Corp.: embecta Completes Acquisition of Owen Mumford Holdings Limited | PARSIPPANY, N.J., May 15, 2026 (GLOBE NEWSWIRE) -- Embecta Corp. ("embecta") (Nasdaq: EMBC), a global leader in diabetes care technology, today announced that it has completed its previously announced... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 26,120 | 0,00 % | PROCEPT BioRobotics Reports First Quarter 2026 Financial Results | SAN JOSE, Calif., April 29, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| AXOGEN | 35,070 | +3,94 % | Axogen, Inc.: Axogen Announces Pricing of Upsized $124 Million Public Offering of Common Stock | ALACHUA, Fla. and TAMPA, Fla., Jan. 21, 2026 (GLOBE NEWSWIRE) -- Axogen, Inc. (Nasdaq: AXGN), a global leader in developing and marketing innovative surgical solutions for the restoration of peripheral... ► Artikel lesen | |
| TACTILE SYSTEMS TECHNOLOGY | 19,810 | +1,17 % | Tactile Systems Technology, Inc.: Tactile Medical Acquires LymphaTech, Expanding Breadth and Depth of its Lymphedema Solutions Portfolio | MINNEAPOLIS, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. ("Tactile Medical"; the "Company") (Nasdaq: TCMD), a medical technology company providing therapies for people with... ► Artikel lesen | |
| APYX MEDICAL | 3,360 | -4,00 % | Apyx Medical Corporation Receives Expanded FDA 510(k) Clearance Adding Power Liposuction Capability to AYON Body Contouring System | CLEARWATER Fla., May 11, 2026 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (Nasdaq: APYX) (the "Company" or "Apyx Medical"), the leader in surgical aesthetics products marketed and sold as Renuvion... ► Artikel lesen | |
| GLAUKOS | 119,00 | -4,03 % | Glaukos - GKOS: Pullback-Setup mit Unterstützung bei 130 USD! | Starkes Wachstum erwartet! Aber Achtung: Insider verkaufen Glaukos-Aktien (GKOS) im Wert von 4.2 Millionen USD! Glaukos (GKOS) - US3773221029 Rückblick: Aufgrund der stark überkauften Situation am US-Gesamtmarkt... ► Artikel lesen | |
| LEXARIA BIOSCIENCE | 0,596 | +0,68 % | Lexaria Bioscience Corp.: Lexaria Bioscience Releases Second Episode of Investor Video Series | CEO Rich Christopher Discusses Recently Announced Material Transfer Agreement Extension and 2026 Research Priorities KELOWNA, BC / ACCESS Newswire / May 7, 2026 / Lexaria Bioscience Corp. (NASDAQ:LEXX)... ► Artikel lesen | |
| ITONIC | 0,310 | +1,94 % | iTonic Holdings Ltd - 6-K, Report of foreign issuer |
ADVANCED BIOMED INC gehört der Branche Gesundheitswesen an. Der aktuelle Kurs liegt bei 4,420 Euro und damit +0,45 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu ADVANCED BIOMED INC finden Sie auf Wallstreet Online.